Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Solubility: DMSO: 100 mg/mL(147
InChi: InChI=1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23
InChiKey: PJDFLNIOAUIZSL-UHFFFAOYSA-N
PND-1186 treatment caused downregulation of FAK Tyr-397 phosphorylation and cyclin D1 amount (Supplementary Figures S8c and d) and increased the expression of both p21 and cleaved caspase-3 at 48 h (Figure 8b)
3-1(4)2(5)6/h2*2
AST 487 - CAS# 630124-46-8 Size:Solid 2 mg Solubility: DMSO: 100 mg/mL(147AST487, also known as NVP AST487, is a RET kinase inhibitor FLT3 inhibitor. The RET kinase has emerged as a promising target for the therapy of medullary thyroid cancers (MTC) and of a subset of papillary thyroid cancers. NVP AST487 has an IC(50) of 0. 88 mumol L on RET kinase, inhibits RET autophosphorylation and activation of downstream effectors, and potently inhibited the growth of human thyroid cancer cell lines with activating mutations of RET
US$ 47.80
US$ 402.50
US$ 110.00
US$ 474.50
US$ 194.50
US$ 270.00
US$ 312.39